                         SEQUENCE LISTING

<110>  Novo Nordisk A/S
 
<120>  NOVEL INSULIN DERIVATIVE

<130>  8721.000-EP

<160>  2     

<170>  PatentIn version 3.5

<210>  1
<211>  21
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Modified Insulin A-chain

<400>  1

Gly Ile Val Glu Gln Cys Cys Thr Ser Ile Cys Ser Leu Glu Gln Leu 
1               5                   10                  15      


Glu Asn Tyr Cys Asn 
            20      


<210>  2
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Modified Insulin B-chain


<220>
<221>  MOD_RES
<222>  (29)..(29)
<223>  Lysine(N(epsilon)-Eicosanedioyl-gGlu-2xOEG)

<400>  2

Phe Val Asn Gln His Leu Cys Gly Ser His Leu Val Glu Ala Leu Glu 
1               5                   10                  15      


Leu Val Cys Gly Glu Arg Gly Phe His Tyr Thr Pro Xaa 
            20                  25                  


